Bcl-B expression in human epithelial and nonepithelial malignancies

Clinical Cancer Research

Volumn 14, Issue 10, 2008, Pages 3011-3021

  Krajewska, Maryla ^a   Kitada, Shinichi ^a   Winter, Jane N ^b   Variakojis, Daina ^b   Lichtenstein, Alan ^c   Zhai, Dayong ^a   Cuddy, Michael ^a   Huang, Xianshu ^a   Luciano, Frederic ^d   Baker, Cheryl H ^e   Kim, Hoguen ^f   Shin, Eunah ^g   Kennedy, Susan ^h   Olson, Allen H ^j   Badzio, Andrzej ^k   Jassem, Jacek ^k   Meinhold Heerlein, Ivo ^l   Duffy, Michaelj ⁱ   Schimmer, Aaron D ^m   Tsao, Ming ^m   Brown, Ewan ^m   Sawyers, Anne ^n,p   Andreeff, Michael ^o   Mercola, Dan ^p   Krajewski, Stan ^a   Reed, John C ^a   more..

^a BURNHAM INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d INSERM   (France)

^e M D ANDERSON CANCER CENTER ORLANDO   (United States)

^f Yonsei University   (South Korea)

^g Inje University College of Medicine   (South Korea)

^h Royal Victoria Eye and Ear Hospital   (Poland)

ⁱ UNIVERSITY COLLEGE DUBLIN   (Ireland)

^j Aperio Technologies   (United States)

^k MEDICAL UNIVERSITY OF GDANSK   (Poland)

^l UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^m PRINCESS MARGARET HOSPITAL   (Canada)

ⁿ SIDNEY KIMMEL CANCER CENTER   (United States)

^o UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCL B PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG; BCL2 LIKE 10 PROTEIN; BCL2-LIKE 10 PROTEIN; TUMOR MARKER;

ARTICLE; B CELL LYMPHOMA; BREAST ADENOCARCINOMA; CANCER SURGERY; COLORECTAL CARCINOMA; FOLLICULAR LYMPHOMA; GENE OVEREXPRESSION; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; BIOSYNTHESIS; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; KAPLAN MEIER METHOD; MALE; METABOLISM; MORTALITY; NEOPLASM; TISSUE MICROARRAY;

FEMALE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TISSUE ARRAY ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 49249102791     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1955     Document Type: Article

References (36)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Reed JC. Mechanisms of apoptosis (Warner/ Lambert Award). Am J Pathol 2000;157:1415-30.
3. Reed JC. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 1996;97:72-100.
4. Ke N, Godzik A, Reed JC. Bcl-B: a novel Bcl-2 family member that differentially binds and regulates Bax and Bak. J Biol Chem 2001;276:12481-4.
5. Zhang H, Holzgreve W, De Geyter C. Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway. Hum Mol Genet 2001;10:2329-39.
6. Chao DT, Korsmeyer SJ. Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395-419.
7. Wang H-G, Reed JC. Mechanisms of Bcl-2 protein function. Histol Histopathol 1998;13:521-30.
8. Inohara N, GourleyTS, Carrio R, et al. Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death. J Biol Chem 1998;273:32479-86.
9. Song Q, Kuang Y, Dixit VM, Vincenz C. Boo, a novel negative regulator of cell death, interactst with Apaf-1. EMBO 1999;18:167-78.
10. Luciano F, Krajewska M, Ortiz-Rubio P. et al. Nur77 converts phenotype of Bcl-B. an antiapoptotic protein expressed in plasma cells and myeloma. Blood 2007; 109:3849-55.
11. Lin B, Kolluri SK, Lin F, et al Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptorTR3/NGFI-B/Nur77 Cell 2004;116 527-40.
12. Went P, Mayer S, Oberholzer M, Dirnhofer S. Plasma cell quantification in bone marrow by computer-assisted image analysis. Histol Histopathol 2006;21:951-6.
13. Krajewska M, Kim H, Kim C, et al Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res 2005;11:5451-61.
14. Krajewska M, Kim H, Shin E, et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res 2005;11:5462-71.
15. Krajewska M, Olson AH, Mercola D, Reed JC, Krajewski S. Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate. Prostate 2007;67:907-10.
16. Meinhold-Heerlein I, Stenner-Liewen F, Liewen H, et al. Expression and potential role of Fas-associated phosphatase-1 (FAP-1) in ovarian cancer. Am J Pathol 2001;158:1335-44.
17. Krajewska M, Krajewski S, Banares S, et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003;9:4914-25.
18. Zhai D, Jin C, Satterthwait AC, Reed JC. Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins. Cell Death Differ 2006;13:1419-21.
19. Krajewski S, Krajewska M, Ellerby LM, et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA 1999;96:5752-7.
20. Krajewska M, Zapata JM, Meinhold-Heerlein I, et al. Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia 2002;4:129-40.
21. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001;23:291-9.
22. Hans CP, Weisenburger DD, GreinerTC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
23. Krajewski S, Zapata JM, Reed JC. Detection of multiple antigens on Western blots. Anal Biochem 1996;236:221-8.
24. Krajewski S, Bodrug S, Krajewska M, et al. Immuno-histochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995;146:1309-19.
25. Elsaleh H.The microsatellite instability phenotype in human colorectal carcinoma: relationship to sex, age, and tumor site. Gastroenterology 2001;121:230-1.
26. Manz RA, Moser K, Burmester GR, Radbruch A, Hiepe F. Immunological memory stabilizing autor-eactivity. Curr Top Microbiol Immunol 2006;305:241-57.
27. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005;5:230-42.
28. Radbruch A, Muehlinghaus G, Luger EO, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006;6:741-50.
29. Shapiro-Shelef M, Lin Kl, Savitsky D, LiaoJ, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med 2005;202:1471-6.
30. Oancea M, Mani A, Hussein MA, Almasan A. Apoptosis of multiple myeloma. Int J Hematol 2004;80:224-31.
31. Chauhan D,Velankar M, Brahmandam M,et al. Anovel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. Oncogene 2007;26:2374-80.
32. Le Gouill S, Podar K, Harousseau JL, Anderson KC. Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 2004;3:1259-62.
33. Cheng WC, Berman SB, Ivanovska I, et al. Mitochondrial factors with dual roles in death and survival. Oncogene 2006;25:4697-705.
34. Cheng E, Clem R, Ravi R, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997;278:1966-8.
35. Clem RJ, Cheng EH, Karp CL, et al. Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci U S A 1998;95:554-9.
36. BivonaTG, Quatela SE, Bodemann BO, etal. PKC regulates a farnesyl-electrostatic switch on K-Rasthat promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 2006;21:481-93.